MARLBOROUGH, Mass. and AMSTERDAM, Aug. 27, 2023 /PRNewswire/ -- Boston Scientific Corporation (BSX) today announced positive 12-month results from the pivotal ADVENT clinical trial of the FARAPULSE™ ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results